Skip to content

HR Chest CT Visual Scoring, Spirometry and Health Related Quality of Life in Evaluating Severity of ILD Patients

High-resolution Chest CT Visual Scoring, Spirometry and Health Related Quality of Life in Evaluating Severity of Interstitial Lung Disease Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05999838
Enrollment
50
Registered
2023-08-21
Start date
2023-10-31
Completion date
2025-02-28
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interstitial Lung Disease

Brief summary

To establish a simplified approach for assessment of severity of interstitial lung disease by evaluating the relationship between HRCT findings, the clinical severity score,spirometry and quality of life.

Detailed description

The interstitial lung diseases are a group of parenchymal pulmonary disorders that affect the interstitium causing progressive fibrosis of lung tissue. These disorders characterized by dyspnea aggravated by exertion . This group of diseases is associated with substantial morbidity and mortality. Thus, a multi-disciplinary approach including clinical, pathological, and radiological correlation is required to reach accurate assessment. The high-resolution computed tomography \[HRCT\] images of the chest are considered the main platform for the diagnostic approach .High-resolution CT (HRCT) scans offer the possibility of measuring disease severity more accurately and sensitively by focusing on fibrotic changes. HRCT images illustrate the presence and extent of parenchymal abnormalities including: reticular opacities, ground-glass opacities, traction bronchiectasis and honeycombing. Most patients with suspected ILDs are likely to undergo complete Pulmonary Function Testing. Usually there is restrictive pulmonary function with decreased TLC (Total Lung Capacity) , FVC (Forced Vital Capacity), FEV1 (Forced Expiratory Volume in One Second) and a normal or increased FEV1/FVC ratio.

Interventions

DIAGNOSTIC_TESTHRCT chest visual scoring

CT-based semi-quantitative scoring will be calculated according to number of lung segments affected on both sides. The finding on each segment will be given a score from 1 to 4 as follows: 1. for ground glass opacities. 2. for reticulations and fibrotic changes. 3. for bronchiectatic changes. 4. for honeycombing and sub-pleural cysts.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years

Inclusion criteria

* All patients admitted at Chest Department or presented to our out patient clinic with clinical diagnosis of Interstitial Lung Diseases among both sexes

Exclusion criteria

* patients under 18 years old. * pregnant patients. * patients with a history of previous lung resections. * presence of bronchial carcinoma or lobar consolidation. * patients contraindicated to perform pulmonary function will be excluded.

Design outcomes

Primary

MeasureTime frame
Correlation of visual based scoring system of HRCT and pulmonary function test.1 year

Secondary

MeasureTime frame
assessment of ILDs patients quality of life and correlation with HRCT finding and PFTs.1 year

Contacts

Primary ContactDina W. Fahim, resident doctor
tinawageh0@gmail.com01287799134
Backup ContactNermeen M. Abu Elkassem, Lecturer
nermenabuelkassem@gmail.com01000767713

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026